Department of Neurology, Center for Translational Research in Neurodevelopmental Disease, Columbia University Irving Medical Center, New York, NY 10032.
Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032.
Proc Natl Acad Sci U S A. 2024 Oct 15;121(42):e2400709121. doi: 10.1073/pnas.2400709121. Epub 2024 Oct 7.
Developmental and epileptic encephalopathies (DEE) are rare but devastating and largely intractable childhood epilepsies. Genetic variants in , encoding a scaffolding protein important for the organization of the postsynaptic density of inhibitory synapses, are associated with DEE accompanied by complex neurological phenotypes. In a mouse model carrying a patient-derived variant associated with severe disease, we observed aggregation of postsynaptic proteins and loss of functional inhibitory synapses at the axon initial segment (AIS), altered axo-axonic synaptic inhibition, disrupted action potential generation, and complex seizure phenotypes consistent with clinical observations. These results illustrate diverse roles of ARHGEF9 that converge on regulation of the structure and function of the AIS, thus revealing a pathological mechanism for -associated DEE. This unique example of a neuropathological condition associated with multiple AIS dysfunctions may inform strategies for treating neurodevelopmental diseases.
发育性和癫痫性脑病 (DEE) 较为罕见,但具有破坏性且在很大程度上难以治疗,是一种严重的儿童癫痫。编码支架蛋白的基因突变与 DEE 相关,该蛋白对于抑制性突触后密度的组织至关重要,同时还伴有复杂的神经表型。在携带与严重疾病相关的患者衍生变异的小鼠模型中,我们观察到突触后蛋白聚集和功能性抑制性突触在轴突起始段 (AIS) 的丢失,改变了轴突-轴突突触抑制,破坏了动作电位的产生,并出现与临床观察一致的复杂癫痫发作表型。这些结果说明了 ARHGEF9 的多种作用,这些作用集中在调节 AIS 的结构和功能上,从而揭示了与 ARHGEF9 相关的 DEE 的病理机制。这种与多种 AIS 功能障碍相关的神经病理学情况的独特例子可能为治疗神经发育性疾病提供策略。